Do we need alternative PD-1 inhibitors for the treatment of renal cell carcinoma?
Article in Expert Opinion on Biological Therapy (June 2024)
The most recent citing publications are shown below. View all 16 publications that cite this research output on Dimensions.
Niraparib for the treatment of metastatic ccRCC in a patient with CDK12 and RAD51C mutations: a case report
Article in Frontiers in Pharmacology (June 2024)
The potential of organoids in renal cell carcinoma research
Article in BMC Urology (June 2024)